SCHEMBL19862878

SCHEMBL19862878

c1ccc2cc(-n3c4ccccc4c4c(-c5ccc6oc7ccccc7c6c5)cc5c6ccccc6oc5c43)ccc2c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 2/20 0.33
SIRT1 Q96EB6 2/20 0.33
ALOX5 P09917 1/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 3/20 0.32
MAPT P10636 3/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
HPGD P15428 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CHEK2 O96017 1/20 0.31
ESR1 P03372 1/20 0.31
POLB P06746 1/20 0.31
LMNA P02545 1/20 0.31
HSP90AA1 P07900 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19862872 0.93 ALOX5 (0.33) ALOX5NPC1RAB9ACYP1A2CYP2C9
SCHEMBL18594161 0.92 SIRT2 (0.33) SIRT2SIRT1ALOX5NPC1RAB9A
SCHEMBL18594108 0.90 KDM4E (0.35) SIRT2SIRT1ALOX5KDM4EALDH1A1
SCHEMBL19862880 0.90 KDM4E (0.35) SIRT2SIRT1ALOX5KDM4EALDH1A1
SCHEMBL18594323 0.89 KDM4E (0.32) SIRT2SIRT1ALOX5KDM4E
SCHEMBL18594167 0.88 PMM2 (0.31) ALOX5NPC1RAB9ACYP1A2CYP2C9
SCHEMBL18594324 0.88 PLA2G2A (0.35) SIRT2SIRT1ALOX5NPC1RAB9A
SCHEMBL18594328 0.88 KDM4E (0.35) SIRT2SIRT1ALOX5KDM4EALDH1A1
SCHEMBL18594106 0.88 ALOX5 (0.36) SIRT2SIRT1ALOX5NPC1RAB9A
SCHEMBL18594269 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 SIRT2 1306/4885SIRT1 1838/4885ALOX5 1089/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 SIRT2 1306/4885SIRT1 1838/4885ALOX5 1089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.